Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 13, Issue 5 pp 6945—6956
Silencing of miR-483-5p alleviates postmenopausal osteoporosis by targeting SATB2 and PI3K/AKT pathway
Figure 1. Expressions of miR-483-5p and SATB2 in clinical samples. (A) Expressions of miR-483-5p in postmenopausal patients with or without osteoporosis. (B) Expressions of SATB2 in postmenopausal patients with or without osteoporosis. (C) Pearson correlation analysis of miR-483-5p expression and SATB2 in osteoporosis samples. (D) Pearson correlation analysis of miR-483-5p expression and SATB2 in control samples. Data were presented as mean ± SD.